Results 171 to 180 of about 61,152 (267)
Targeting Multiple Gut‐Brain Pathways in Obesity: Rationale for Combination Pharmacotherapy
ABSTRACT Background As a disease of energy dysregulation, obesity involves metabolic, hormonal, and neural factors, the interconnection of which is referred to as the “gut‐brain axis.” Objective This review aimed to provide an overview of the clinical evidence of physiological and objective or subjective changes in eating behavior with gut hormone ...
Alexander D. Miras, Muzamil Hussain
wiley +1 more source
Intra-mitochondrial sorting of precursor proteins [PDF]
Brown, Alistair J. P. +3 more
core +1 more source
Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies. [PDF]
Alhazmi A, le Roux CW.
europepmc +1 more source
SGLT2 inhibitors reduce skeletal muscle mass modestly in older adults with type 2 diabetes. Forest plot (a) and count our funnel plot (b) show a small but significant pooled reduction in muscle mass (SMD = −0.36, 95% CI [−0.56, −0.15]; I2 = 24.1%), with weight loss occurring predominantly through fat mass reduction.
Weena Joongpan +5 more
wiley +1 more source
Life-course influence of birthweight and subsequent pathways on healthy aging: a Mendelian randomization study. [PDF]
Kong L +16 more
europepmc +1 more source
The Mitochondrial Protein Import Apparatus [PDF]
Neupert, Walter, Pfanner, Nikolaus
core +1 more source
OSA Endotyping as Targets for Treatment. How Far Have We Come?
ABSTRACT Obstructive sleep apnoea (OSA) is highly prevalent and is associated with significant impairments in quality of life and comorbidity. The most common treatment employed is continuous positive airway pressure (CPAP), especially in moderate and severe cases.
Walter T. McNicholas +4 more
wiley +1 more source
Gastric inverted polyp mimicking submucosal tumor. [PDF]
Ma C, Hu Z, Zhu S, Jing D.
europepmc +1 more source

